Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study

BACKGROUND: Severe eosinophilic asthma is frequently associated to chronic rhinosinusitis and nasal polyposis (CRSwNP) that contribute to poor asthma control. Mepolizumab is an anti-IL-5 monoclonal antibody, approved for the treatment of severe eosinophilic asthma. A limited number of studies have a...

詳細記述

保存先:
書誌詳細
出版年:Ther Adv Respir Dis
主要な著者: Detoraki, Aikaterini, Tremante, Eugenio, D’Amato, Maria, Calabrese, Cecilia, Casella, Claudia, Maniscalco, Mauro, Poto, Remo, Brancaccio, Raffaele, Boccia, Matilde, Martino, Maria, Imperatore, Clara, Spadaro, Giuseppe
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2021
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107661/
https://ncbi.nlm.nih.gov/pubmed/33910399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17534666211009398
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料